Cerus Corporation is a biomedical products company focused on commercializing the INTERCEPT Blood System to enhance blood safety. Cerus currently markets and sells the INTERCEPT Blood System for both platelets and plasma in Europe, Russia, the Middle East and selected countries in other regions around the world.
Type
Public
HQ
Concord, US
Founded
1991
Size (employees)
204 (est)
Website
cerus.com
Cerus was founded in 1991 and is headquartered in Concord, US
Report incorrect company information

Key People/Management at Cerus

William M. Greenman

William M. Greenman

President and CEO
Kevin D. Green

Kevin D. Green

VP, Finance & CFO
Laurence M. Corash

Laurence M. Corash

Svp, CMO & CSO
Show more

Cerus Office Locations

Cerus has offices in Concord and Amersfoort
Concord, US (HQ)
2550 Stanwell Dr
Amersfoort, NL
79 Stationsstraat
Show all (2)
Report incorrect company information

Cerus Financials and Metrics

Cerus Revenue

Cerus 's revenue was reported to be $39.28 m in FY, 2016 which is a 14.8% increase from the previous period.
USD

Net income (Q1, 2018)

(13.9 m)

EBIT (Q1, 2018)

(13.4 m)

Market capitalization (18-Jul-2018)

959.5 m

Closing share price (18-Jul-2018)

7.4

Cash (31-Mar-2018)

14.9 m
Cerus 's current market capitalization is $959.5 m.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

39.7 m36.4 m34.2 m39.3 m

Revenue growth, %

(8%)(6%)15%

Cost of goods sold

22.6 m21.2 m23.5 m20.3 m

Gross profit

17.1 m15.2 m10.8 m19 m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018

Revenue

8.6 m10.4 m7.7 m8.8 m8 m7.6 m9.3 m

Cost of goods sold

4.8 m5.7 m4.7 m7 m5.6 m4.3 m5 m

Gross profit

3.8 m4.7 m3 m1.8 m2.5 m3.4 m4.3 m

Gross profit Margin, %

45%45%39%20%31%44%46%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

29.5 m22.8 m71 m22.6 m13.7 m

Accounts Receivable

6.1 m5.5 m5.8 m6.9 m12.4 m

Inventories

13.1 m15 m10.8 m12.5 m14.5 m

Current Assets

78.2 m74.9 m130.4 m94.1 m89.9 m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018

Cash

24.4 m24 m28.6 m22.3 m17.9 m35.1 m50.8 m20.8 m7.7 m12.9 m10.9 m20.3 m14.9 m

Accounts Receivable

7 m4.9 m4.5 m7.4 m5.2 m5.4 m5.6 m4.1 m5.1 m7.4 m5.6 m7.9 m10.5 m

Inventories

12.7 m11.3 m13.4 m13.5 m16.1 m13.7 m12.8 m11.3 m12.1 m12.2 m12.9 m12.2 m13.2 m

Current Assets

74.5 m67.1 m70.3 m72.7 m136.4 m144.5 m128.4 m119.4 m112.2 m108 m75.7 m74.3 m133.8 m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(43.3 m)(38.8 m)(55.9 m)(62.9 m)(60.6 m)

Depreciation and Amortization

202 k202 k202 k202 m1.8 m

Inventories

(1.8 m)3 m4 m(1.8 m)(2.1 m)

Accounts Payable

(1.5 m)(973 k)(3.9 m)3.3 m2.5 m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q1, 2018

Net Income

(20.5 m)(225 k)(7.6 m)(10.8 m)(9.5 m)(16 m)(15.7 m)(16.9 m)(18.2 m)(14.4 m)(18.6 m)(13.9 m)

Depreciation and Amortization

51 k50 k50 k51 k50 k50 k51 k50 k50 k413 k

Inventories

13.4 m13.5 m16.1 m13.7 m12.8 m11.3 m12.1 m12.2 m12.9 m1.2 m

Accounts Payable

3.2 m4.1 m10.5 m5.8 m6.8 m6.2 m7.2 m6.9 m8.8 m(122 k)
USDY, 2018

Financial Leverage

1.7 x
Show all financial metrics

Cerus Operating Metrics

FY, 2016

Patents Issued

93
Show all operating metrics
Report incorrect company information

Cerus Online and Social Media Presence

Embed Graph
Report incorrect company information

Cerus Company Life and Culture

Report incorrect company information